Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · JACKSONVILLE, FL · NPI 1184696478
Verified facts
CMS Open Payments records show Robert Neils Miller, M.D. received $24.84 in general payments during 2025 across 1 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $24.84 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $24.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 399 | 137 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 387 | 147 |
| Amlodipine Besylate | Amlodipine Besylate | 346 | 119 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 296 | 87 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 275 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 236 | 81 |
| Furosemide | Furosemide | 204 | 79 |
| Meloxicam | Meloxicam | 180 | 73 |
| Losartan Potassium | Losartan Potassium | 175 | 66 |
| Gabapentin | Gabapentin | 174 | 70 |
| Lisinopril | Lisinopril | 171 | 60 |
| Metoprolol Succinate | Metoprolol Succinate | 163 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 159 | 50 |
| Carvedilol | Carvedilol | 145 | 48 |
| Metformin Hcl Er | Metformin Hcl | 132 | 51 |
| Metformin Hcl | Metformin Hcl | 131 | 46 |
| Montelukast Sodium | Montelukast Sodium | 119 | 52 |
| Fluticasone Propionate | Fluticasone Propionate | 112 | 45 |
| Omeprazole | Omeprazole | 111 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 111 | 46 |
| Ibuprofen | Ibuprofen | 107 | 68 |
| Tizanidine Hcl | Tizanidine Hcl | 107 | 45 |
| Potassium Chloride | Potassium Chloride | 104 | 38 |
| Diclofenac Sodium | Diclofenac Sodium | 94 | 70 |
| Metoprolol Tartrate | Metoprolol Tartrate | 94 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 92 | 32 |
| Trazodone Hcl | Trazodone Hcl | 90 | 37 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 89 | 40 |
| Naproxen | Naproxen | 89 | 52 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 88 | 32 |
| Baclofen | Baclofen | 86 | 29 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 14 |
| Alprazolam | Alprazolam | 77 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 75 | 26 |
| Alendronate Sodium | Alendronate Sodium | 73 | 29 |
| Spironolactone | Spironolactone | 73 | 24 |
| Glipizide | Glipizide | 72 | 23 |
| Jardiance | Empagliflozin | 72 | 22 |
| Sertraline Hcl | Sertraline Hcl | 68 | 27 |
| Eliquis | Apixaban | 65 | 19 |
| Ezetimibe | Ezetimibe | 60 | 23 |
| Finasteride | Finasteride | 58 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 55 | 22 |
| Meclizine Hcl | Meclizine Hcl | 55 | 20 |
| Warfarin Sodium | Warfarin Sodium | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 50 | 17 |
| Glimepiride | Glimepiride | 48 | 16 |
| Sildenafil Citrate | Sildenafil Citrate | 47 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 18 |
| Prednisone | Prednisone | 44 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | 15 |
| Ondansetron Odt | Ondansetron | 43 | 23 |
| Donepezil Hcl | Donepezil Hcl | 42 | 18 |
| Allopurinol | Allopurinol | 41 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 14 |
| Tramadol Hcl | Tramadol Hcl | 41 | 30 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 30 |
| Famotidine | Famotidine | 39 | 23 |
| Methylprednisolone | Methylprednisolone | 39 | 34 |
| Clonazepam | Clonazepam | 38 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Simvastatin | Simvastatin | 37 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 35 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 34 | 11 |
| Entresto | Sacubitril/Valsartan | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | 12 |
| Mirtazapine | Mirtazapine | 28 | suppressed |
| Nifedipine Er | Nifedipine | 28 | 15 |
| Azithromycin | Azithromycin | 27 | 23 |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | 11 |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 15 |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Lorazepam | Lorazepam | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | 13 |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 11 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.84 · 1 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error